Cite

HARVARD Citation

    Martins-Filho, S. et al. (2020). EGFR-mutated lung adenocarcinomas from patients who progressed on EGFR-inhibitors show high engraftment rates in xenograft models. Lung cancer. pp. 144-151. [Online]. 
  
Back to record